Steve Scott Appointed Head of Finance of Cambridge Healthcare Research

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

March 25, 2021

Steve Scott offers the group a wealth of experience in finance and operations, with his international exposure to large, global, multi-function teams as well as his dedication to driving efficiencies, strengthening controls, and delivering substantial cost savings at the operating level. He will report to CEO Chris Stevenson.

Commenting on the appointment, Chris said, “With Steve joining our team we can continue our plan to strengthen the finance function in CHR. We are a rapidly growing business and we continue to evolve how we provide our best services for both our internal and external customers. Having a strong and effective finance function will ensure that we can best support our teams and provide the internal analytics to optimize the way we operate. This supports our consistent goal of being a leader in the understanding and strategic interpretation of healthcare markets for our clients.”

Steve Scott is a proven and respected leader in finance with extensive commercial experience in global finance roles across multi-functional teams. He is a qualified accountant with the ACCA and has just returned to the UK having worked in the US for the last eight years. Steve joins CHR from McCarthy Law, plc in Arizona, where he was Financial Controller. With well over 20 years in financial leadership roles, Steve’s previous roles include time at Travelex, Western Union and Shell Oil and Gas Corporation.

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.